Exelixis, Inc. (EXEL) stock forecast and price target
Price $69.00 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($69.00)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $3.75 | +21.8% | $2.6B |
| Next fiscal year ends December 31, 2027 | $4.27 | +13.9% | $2.9B |
| Next quarter ends December 31, 2026 | $1.03 | +9.2% | $658M |
| Quarter after ends March 31, 2027 | $0.88 | +1.1% | $691M |
Consensus of the analysts covering Exelixis, updated daily. In the last 30 days 6 estimates were raised and 0 lowered.
Our model vs. Wall Street
Analysts see 10.8% downside over 12 months. Our discounted cash flow model with moderate assumptions puts Exelixis’s intrinsic value about 14% above today’s market value, and it scores 4.4 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the Exelixis stock price target?
The average 12-month target from 14 analysts is $61.57, 10.8% below the current price of $69.00 Targets range from $41.00 to $78.00.
Is Exelixis a buy according to analysts?
The consensus rating is “Buy” (1 strong buy, 5 buy, 10 hold, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.
How much is Exelixis expected to earn?
Analysts expect EPS of $3.75 for the fiscal year ending December 31, 2026 and $4.27 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.